This case highlights the potential risk of fatal fulminant myocarditis exacerbation due to HHV-6 reactivation following immunosuppressive steroid therapy for acute hepatitis.
Answers are grounded in this paper and cite their sources.
May link steroid immunosuppression in hepatitis to HHV-6 myocarditis exacerbation; hypothesis-generating and requires prospective validation.
We report a case of fulminant myocarditis after steroid pulse therapy for acute hepatitis. Serological studies demonstrated a four-fold increase in the antibodies against human herpesvirus-6 (HHV-6) IgG, and a PCR showed the existence of HHV-6 virus DNA. HHV-6 virus DNA was also isolated from the liver and the heart. We believe that exacerbation of fulminant myocarditis was probably associated with the reactivation of HHV-6 due to the immunosuppressive state of the host.
No takes yet. Share an insight, caveat, or question.
Fukae et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: